Prostate cancer in Black men is diagnosed at significantly higher rates than in White men, and new medical guidelines are calling for earlier, more frequent screening to help reduce preventable deaths.
The conversation around prostate cancer comes as Jackson 5 star Marlon Jackson, 69, recently revealed that he has been living with stage 4 prostate cancer for four years. During an appearance on “The Farah Shammas Podcast,” the singer shared that he underwent surgery to remove his prostate gland and received radiation treatment. Despite his diagnosis, Jackson expressed optimism about his health, saying, “I’m great. I’m good. Bad grass don’t die. So, I’m going to be around for a long time.”
The American Cancer Society updated its prostate cancer screening recommendations on November 12, 2026, advising Black men to begin annual testing at age 45. The changes follow years of research documenting racial disparities in diagnosis, treatment, and survival.
According to the organization, Black men have a 67% higher prostate cancer incidence rate than White men and are nearly twice as likely to die from the disease.
Dr. William Dahut, chief scientific officer at the American Cancer Society, described the disparity as “an inequity that needs immediate reversal.”
The numbers help explain why prostate cancer remains one of the most pressing health concerns affecting Black men nationwide.
The American Cancer Society estimates that approximately 333,830 men will receive a prostate cancer diagnosis in the United States in 2026, with 36,320 deaths expected.
Made to order and shipped to your door.
Although the disease affects men of all racial backgrounds, Black men are more likely to develop prostate cancer at younger ages and face an increased risk of advanced disease.
Researchers have identified several possible contributors to these differences, including inherited risk factors, aggressive tumor characteristics, unequal healthcare access, and delays in receiving appropriate treatment.
Studies also show that Black patients may face barriers to specialized cancer care, including financial challenges and reduced access to medical facilities offering advanced treatment.
These disparities cannot be explained by genetics alone.
Family history is another major consideration. Men whose fathers, brothers, or sons have experienced prostate cancer face an increased likelihood of developing the disease themselves.
Inherited genetic changes, including certain BRCA2 mutations, can also increase prostate cancer risk.
For men with a significant family history, discussing genetic counseling and screening options with a healthcare professional may help determine an appropriate approach.
One challenge with prostate cancer is that it frequently develops without noticeable symptoms.
According to the Centers for Disease Control and Prevention, most men with early prostate cancer experience no warning signs.
When symptoms occur, they may include difficulty urinating, blood in the urine or semen, and persistent pain in the back, hips, or pelvis.
These symptoms can also result from noncancerous conditions, meaning medical evaluation is necessary to determine their cause.
Waiting until symptoms appear can allow an aggressive cancer to progress before detection.
Under the American Cancer Society’s updated recommendations, Black men should receive a prostate-specific antigen blood test annually between ages 45 and 69.
The test measures PSA, a protein produced by the prostate gland. Elevated levels can indicate cancer but may also result from inflammation or an enlarged prostate.
An abnormal result does not automatically mean someone has cancer.
Doctors may recommend repeating the blood test, obtaining an MRI, or using additional testing before deciding whether a biopsy is necessary.
For men at average risk, the organization recommends screening every two years between ages 50 and 69.
Dr. Robert Smith, an American Cancer Society screening expert, emphasized that “PSA testing remains the cornerstone of detecting prostate cancer early.”
Screening has potential drawbacks, including false alarms and the detection of slow-growing cancers that might never cause symptoms. Patients should understand these possibilities before testing.
Treatment depends on how aggressive the cancer is and whether it has spread.
Options include surgery, radiation therapy, hormone therapy, medication, and active surveillance, which involves closely monitoring lower-risk cancers without immediately starting treatment.
Some treatments can cause urinary, bowel, or sexual side effects.
Medical advances have improved outcomes, but access to timely diagnosis and quality treatment remains a challenge for some patients.
Black men who have concerns about prostate cancer can discuss their personal risk, family medical history, and screening schedule with a healthcare provider.
For men approaching 45, that conversation may begin before any symptoms appear.



